Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998

American Journal of Clinical Nutrition

Volumn 71, Issue 2, 2000, Pages 405-411

  De Roos, Nicole M ^a   Katan, Martijn B ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NONE

Author keywords

Carcinogenesis; Cholesterol; Diarrhea; Enterococcus; Lactobacillus; Lipid metabolism; Probiotic bacteria; Review; Rotavirus

Indexed keywords

PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; CARCINOGENESIS; CHOLESTEROL BLOOD LEVEL; DIARRHEA; ENTEROCOCCUS; FOOD INTAKE; LACTOBACILLUS ACIDOPHILUS; LIPID METABOLISM; REVIEW; ROTAVIRUS; TUMOR GROWTH; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BIFIDUM; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; ROTAVIRUS;

EID: 0033972192     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.2.405     Document Type: Review

References (80)

1. Fuller R. Probiotic foods. Current use and future developments. Int Food Ingred 1993;3:23-6.
2. Fuller R. Probiotics in man and animals. A review. J Appl Bacteriol 1989;66:365-78.
3. Lee Y-K, Salminen S. The coming of age of probiotics. Trends Food Sci.Technol 1995;6:241-5.
4. Sanders ME. Summary of conclusions from a consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures. J Dairy Sci 1993;76:1819-28.
5. Salminen S, Isolauri E, Salminen E. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996;70:347-58.
6. De Simone C, Rosati E, Moretti S, Salvadori B, Vesely R, Jirillo E. Probiotics and stimulation of the immune response. Eur J Clin Nutr 1991;45:32-4.
7. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870-6.
8. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtiere L, Salminen S. Survival of Lactobaciltus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121-8.
9. Hitchins AD, McDonough FEM. Prophylactic and therapeutic aspects of fermented milk. Am J Clin Nutr 1989;49:675-84.
10. Huis in't Veld JHJ, Havenaar R, Marteau P. Establishing a scientific basis for probiotic R&D. Trends Biotechnol 1994;12:6-8.
11. O'Sullivan MG, Thornton G, O'Sullivan GC, Collins JK. Probiotic bacteria: myth or reality? Trends Food Sci Technol 1992;3:309-14.
12. Perdigon G, Alvarez S, Rachid M, Agüero G, Gobbato N. Immune stimulation by probiotics. J Dairy Sci 1995;78:1597-606.
13. McFarland LV, Elmer GW. Pharmaceutical probiotics for the treatment of anaerobic and other infections. Anaerobe 1997;3:73-8.
14. Salminen S, Laine M, von Wright A, Vuopio-Varkila J, Korhonen T, Mattila-Sandholm T. Development of selection criteria for probiotic strains to assess their potential in functional foods: a Nordic and European approach. Biosci Microflora 1996;15:61-7.
15. Tamime AY, Marshall VM, Robinson RK. Microbiological and technological aspects of milks fermented by bifidobacteria. J Dairy Res 1995;62:151-87.
16. Duffy LC, Zielezny MA, Riepenhoff-Talty M, et al. Reduction of virus shedding by B. bifidum in experimentally induced MRV infection. Dig Dis Sci 1994;39:2334-40.
17. Duffy LC, Zielezny MA, Riepenhoff-Talty M, et al. Effectiveness of Bifidobacterium bifidum in mediating the clinical course of murine rotavirus diarrhea. Pediatr Res 1994;35:690-5.
18. Jack RW, Tagg JR, Ray B. Bacteriocins of gram-positive bacteria. Microbiol Rev 1995;59:171-200.
19. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998;52:1-9.
20. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996;40:137-45.
21. Majamaa M, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
22. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994;10:55-64.
23. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-7.
24. Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997; 66(suppl):515S-20S.
25. De Simone C, Ciardi A, Grassi A, et al. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992; 14:331-40.
26. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus Casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-7.
27. Isolauri E, Kaila M, Mykkänen H, Ling WH, Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994;39:2595-600.
28. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995;72:51-3.
29. Kaila M, Isolauri E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32: 141-4.
30. Majamaa M, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995;20:333-8.
31. Shornikova A-V, Isolauri E, Burnakova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997;86:460-5.
32. Pant AR, Graham SM, Allen SJ, et al. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 1996;42: 162-5.
33. Guarino A, Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997;25:516-9.
34. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995;13:310-2.
35. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344:1046-9.
36. Bin LX. Étude contrôlée du Lactéol Fort sachets versus furazolidone ou berbérine dans le traitement des diarrhées aiguës de l'enfant. (Controlled clinical trial in infants and children comparing Lacteol Fort sachets with two antidiarrheal reference drugs.) Ann Pediatr (Paris) 1995;42:396-401 (in French).
37. Boulloche J, Mouterde O, Mallet E. Traitement des diarrhées aiguës ches le nourisson et le jeune enfant. (Management of acute diarrhea in infants and toddlers.) Ann Pediatr (Paris) 1994;41:457-63 (in French).
38. Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989;17:333-8.
39. Mitra AK, Rabbani GH. A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli. Gastroenterology 1990;99:1149-52.
40. Buydens P, Debeuckelaere S. Efficacy of SF68 in the treatment of acute diarrhea. A placebo-controlled trial. Scand J Gastroenterol 1996;31:887-91.
41. Drago L, Gismondo MR, Lombardi A, de Haen C, Gozzini L. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 1997; 153:455-63.
42. Jin LZ, Ho YW, Abdullah N, Ali MA, Jalaludin S. Antagonistic effects of intestinal Lactobacillus isolates on pathogens of chicken. Lett Appl Microbiol 1996;23:67-71.
43. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995;79:475-9.
44. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30.
45. Ishihara K, Miyakawa H, Hasegawa A, Takazoe I, Kawai Y. Growth inhibition of Streptococcus mutans by cellular extracts of human intestinal lactic acid bacteria. Infect Immun 1985;49:692-4.
46. Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990;22:57-9.
47. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995;21:224-6.
48. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;2:1519 (letter).
49. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. Ann Pharmacol 1990;24:382-4.
50. Witsell DL, Garrett CG, Yarbrough WG, Dorrestein SP, Drake AF, Weissler MC. Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective randomized trial. J Otolaryngol 1995;24:230-3.
51. Black F, Einarsson K, Lidbeck A, Orrhage K, Nord CE. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scand J Infect Dis 1991;23:247-54.
52. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993;328:1821-7.
53. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990;22:53-6.
54. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997;4:41-3.
55. Katelaris PH, Salam I, Farthing MJG. Lactobacilli to prevent traveler's diarrhea? N Engl J Med 1995;333:1360-1.
56. Gilliland SE, Nelson CR, Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol 1985;49:377-81.
57. Gilliland SE, Noh DO. Influence of bile salts on β-galactosidase activity and cellular integrity of Lactobacillus acidophilus. Animal Sci Res Rep 1989:257.
58. Gilliland SE, Walker DK. Cholesterol uptake by culture of Lactobacillus acidophilus used for nonfermented acidophilus milk. Anim Sci Res Rep 1989:258-62.
59. Klaver FAM, Van der Meer R. The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol 1993;59:1120-4.
60. Tahri K, Ballongue J, Schneider F. Effects of three strains of bifidobacteria on cholesterol. Lett Appl Microbiol 1995;21:149-51.
61. Marteau P, Gerhardt MF, Myara A, Bouvier E, Trivin F, Rambaud J-C. Metabolism of bile salts by alimentary bacteria during transit in the human small intestine. Microbiol Ecol Health Dis 1995;8:151-7.
62. Lin SY, Ayres JW, Winkler W, Sandine WE. Lactobacillus effects on cholesterol: in vitro and in vivo results. J Dairy Res 1989;72:2885-99.
63. Khedkar CD, Garge RD, Mantri JM, Kulkarni SA, Khedkar GD. Effect of feeding acidophilus milk on serum cholesterol in human volunteers. J Dairy Foods Home Sci 1993;12:33-8.
64. Schaafsma G, Meuling WJA, Van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 1998;52:436-40.
65. De Roos NM, Scheuten G, Katan MB. Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr 1999;53:277-80.
66. Agerbæk M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995;49:346-52.
67. Richelsen B, Kristensen K, Pedersen SB. Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double blind study. Eur J Clin Nutr 1996;50:811-5.
68. Aso Y, Akazan H, BLP Study Group. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 1992;49:125-9.
69. Aso Y, Akazan H, Kotake T, Tsukamoto T, Imai K, BLP Study Group. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur Urol 1995;27:104-9.
70. Orrhage K, Sillerstrom E, Gusfafsson JA, Nord CE, Rafter J. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res 1994;311:239-48.
71. Felton JS, Malfatti MA, Knize MG, Salmon CP, Hopmans EC, Wu RW. Health risks of heterocyclic amines. Mutat Res 1997;376:37-41.
72. Lidbeck A, Nord CE, Rafter J, Nord C, Gustaffson J-Å. Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans. Microbiol Ecol Health Dis 1992;5:59-67.
73. Korpela R. Role of rye fibre and Lactobacillus GG in colonic metabolism. PhD thesis. Kuopio University, Finland, 1995.
74. Hayatsu H, Hayatsu T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 1993;73: 173-9.
75. Ling WH, Korpela R, Mykkanen H, Salminen S, Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124:18-23.
76. Ling WH, Hänningen O, Mykkänen H, Heikura M, Salminen S, von Wright A. Colonization and fecal enzyme activities after oral Lactobacillus GG administration in elderly nursing home residents. Ann Nutr Met 1992;36:162-6.
77. Bouhnik Y, Flourié B, Andrieux C, Bisetti N, Briet F, Rambaud J-C. Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. Eur J Clin Nutr 1996;50:269-73.
78. Marteau P, Pochart P, Flourié B, et al. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic microflora. Am J Clin Nutr 1990;52:685-8.
79. Halpern GM, Vruwink KG, Van de Water J, Keen CL, Gershwin ME. Influence of long-term yoghurt consumption in young adults. Int J Immunother 1991;7:205-10.
80. Solis Pereyra B, Lemonnier D. Induction of human cytokines by bacteria used in dairy foods. Nutr Res 1993;13:1127-40.